# Determinants of Antiretroviral Treatment Adherence Among Young Mothers Living with HIV: The Role of Early Motherhood

**Authors:** Siyanai Zhou, Christina Laurenzi, Janke Tolmay, Camille Wittesaele, Nontokozo Langwenya, Alice Armstrong, Laurie Gulaid, Elona Toska

PMC · DOI: 10.1007/s10461-025-04896-4 · AIDS and Behavior · 2025-10-15

## TL;DR

Young mothers with HIV who gave birth before 18 are less likely to stick to their treatment, but support from caregivers and psychosocial help can improve adherence.

## Contribution

This study identifies age at first birth as a novel determinant of ART adherence among young mothers living with HIV in South Africa.

## Key findings

- Early motherhood (<18 years) was associated with lower ART adherence compared to those who gave birth at 18+ years.
- Psychosocial support and caregiver presence significantly improved ART adherence, especially for those with internalized HIV stigma.
- Combined psychosocial and caregiver support showed stronger effects in improving adherence among young mothers with HIV.

## Abstract

Adolescent girls living with HIV are at higher risk of poor HIV treatment outcomes than older women living with HIV. However, little is known about how age at first birth influences their adherence to antiretroviral treatment (ART). Using South African data from a cross-sectional study of 311 young mothers living with HIV (N = 311, mean age 19.7 ± 1.92 years, follow-up = 2017–2018), we examined the association between age at first birth (< 18 versus 18+ years), all hypothesized factors and self-reported past-week ART adherence, adjusting for known covariates. We computed adjusted probability estimates conditional on the presence of none, one, or all factors significantly associated with ART adherence in the final regression model. Overall, 45% (N = 140) of participants had their first birth before the age of 18. ART adherence rates differed significantly by age at first birth (< 18 years: 67.9% vs. 18+ years: 80.1%, p = 0.013). Age-at-first birth (< 18 years) (aOR 0.45, 95% CI 0.26–0.78, p = 0.005) and internalized HIV stigma (aOR 0.33, 95% CI 0.17–0.62, p = 0.001) were associated with lower odds of past-week adherence, while psychosocial support (aOR 2.39, 95% CI 1.20–4.74, p = 0.013) and availability of a caregiver for the participant (aOR 2.74, 95% CI 1.37–5.52, p = 0.005) were associated with higher odds of past-week adherence. Combined psychosocial support and caregiver presence improved ART adherence among young mothers, with stronger effects in those reporting internalized HIV stigma. Efforts to support young mothers to improve their adherence to ART are urgently needed at scale, including strategies to reduce the impact of HIV-related stigma, including family psychosocial support.

The online version contains supplementary material available at 10.1007/s10461-025-04896-4.

## Full-text entities

- **Diseases:** HIV (MESH:D015658)
- **Species:** Homo sapiens (human, species) [taxon 9606], Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12988881/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12988881/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12988881/full.md

---
Source: https://tomesphere.com/paper/PMC12988881